Inhibition of Wnt1 expression reduces the enrichment of cancer stem cells in a mouse model of breast cancer

Biochemical and Biophysical Research Communications

Volumn 425, Issue 2, 2012, Pages 436-442

  Choi, A Ram ^a   Park, Jeong Ran ^a,d   Kim, Ran Ju ^a   Kim, Soo Rim ^a   Cho, Sung Dae ^b   Jung, Ji Youn ^c   Nam, Jeong Seok ^a  

^a Gachon University College of Medicine   (South Korea)

^b Chonbuk National University   (South Korea)

^c Kongju National University   (South Korea)

^d Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

Author keywords

Breast cancer; Cancer stem cells; Wnt1

Indexed keywords

ALDEHYDE DEHYDROGENASE; RECOMBINANT PROTEIN; RECOMBINANT WNT1 PROTEIN; STEM CELL FACTOR; UNCLASSIFIED DRUG; WNT1 PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER STEM CELL; CARCINOGENESIS; CELL GROWTH; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION; GENE OVEREXPRESSION; GENE REPRESSION; GENE TARGETING; GROWTH INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION;

ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; DISEASE MODELS, ANIMAL; FEMALE; GENE KNOCKDOWN TECHNIQUES; HUMANS; MICE; NEOPLASTIC STEM CELLS; WNT1 PROTEIN;

MOUSE MAMMARY TUMOR VIRUS;

EID: 84865353086     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.07.120     Document Type: Article

References (34)

1. Lodha R.S., Nandeshwar S., Pal D.K., Shrivastav A., Lodha K.M., Bhagat V.K., Bankwar V.V., Saxena D.M. Risk factors for breast cancer among women in Bhopal urban agglomerate: a case-control study. Asian Pac. J. Cancer Prev. 2011, 12:2111-2115.
2. Goldfarb Y., Ben-Eliyahu S. Surgery as a risk factor for breast cancer recurrence and metastasis: mediating mechanisms and clinical prophylactic approaches. Breast Dis. 2006, 26:99-114.
3. Ganz P.A., Kwan L., Stanton A.L., Bower J.E., Belin T.R. Physical and psychosocial recovery in the year after primary treatment of breast cancer. J. Clin. Oncol. 2011, 29:1101-1109.
4. Gupta P.B., Chaffer C.L., Weinberg R.A. Cancer stem cells: mirage or reality?. Nat. Med. 2009, 15:1010-1012.
5. Fan X., Liu S., Su F., Pan Q., Lin T. Effective enrichment of prostate cancer stem cells from spheres in a suspension culture system. Urol. Oncol. 2012, 30:314-318.
6. Shi X., Gipp J., Bushman W. Anchorage-independent culture maintains prostate stem cells. Dev. Biol. 2007, 312:396-406.
7. Cao L., Zhou Y., Zhai B., Liao J., Xu W., Zhang R., Li J., Zhang Y., Chen L., Qian H., Wu M., Yin Z. Sphere-forming cell subpopulations with cancer stem cell properties in human hepatoma cell lines. BMC Gastroenterol. 2011, 11:71.
8. Dontu G., Abdallah W.M., Foley J.M., Jackson K.W., Clarke M.F., Kawamura M.J., Wicha M.S. In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev. 2003, 17:1253-1270.
9. Techawattanawisal W., Nakahama K., Komaki M., Abe M., Takagi Y., Morita I. Isolation of multipotent stem cells from adult rat periodontal ligament by neurosphere-forming culture system. Biochem. Biophys. Res. Commun. 2007, 357:917-923.
10. Aslakson C.J., Miller F.R. Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor. Cancer Res. 1992, 52:1399-1405.
11. Kim R.J., Kim S.R., Roh K.J., Park S.B., Park J.R., Kang K.S., Kong G., Tang B., Yang Y.A., Kohn E.A., Wakefield L.M., Nam J.S. Ras activation contributes to the maintenance and expansion of Sca-1pos cells in a mouse model of breast cancer. Cancer Lett. 2010, 287:172-181.
12. Schwab L.P., Peacock D.L., Majumdar D., Ingels J.F., Jensen L.C., Smith K.D., Cushing R.C., Seagroves T.N. Hypoxia-inducible factor 1alpha promotes primary tumor growth and tumor-initiating cell activity in breast cancer. Breast Cancer Res. 2012, 14:R6.
13. Nam J.S., Kang M.J., Suchar A.M., Shimamura T., Kohn E.A., Michalowska A.M., Jordan V.C., Hirohashi S., Wakefield L.M. Chemokine (C-C motif) ligand 2 mediates the prometastatic effect of dysadherin in human breast cancer cells. Cancer Res. 2006, 66:7176-7184.
14. Zhang S., Balch C., Chan M.W., Lai H.C., Matei D., Schilder J.M., Yan P.S., Huang T.H., Nephew K.P. Identification and characterization of ovarian cancer-initiating cells from primary human tumors. Cancer Res. 2008, 68:4311-4320.
15. Gal H., Makovitzki A., Amariglio N., Rechavi G., Ram Z., Givol D. A rapid assay for drug sensitivity of glioblastoma stem cells. Biochem. Biophys. Res. Commun. 2007, 358:908-913.
16. Alison M.R., Lim S.M., Nicholson L.J. Cancer stem cells: problems for therapy?. J. Pathol. 2011, 223:147-161.
17. Ginestier C., Hur M.H., Charafe-Jauffret E., Monville F., Dutcher J., Brown M., Jacquemier J., Viens P., Kleer C.G., Liu S., Schott A., Hayes D., Birnbaum D., Wicha M.S., Dontu G. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 2007, 1:555-567.
18. Huang E.H., Hynes M.J., Zhang T., Ginestier C., Dontu G., Appelman H., Fields J.Z., Wicha M.S., Boman B.M. Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis. Cancer Res. 2009, 69:3382-3389.
19. Nusse R., van Ooyen A., Cox D., Fung Y.K., Varmus H. Mode of proviral activation of a putative mammary oncogene (int-1) on mouse chromosome 15. Nature 1984, 307:131-136.
20. Tsukamoto A.S., Grosschedl R., Guzman R.C., Parslow T., Varmus H.E. Expression of the int-1 gene in transgenic mice is associated with mammary gland hyperplasia and adenocarcinomas in male and female mice. Cell 1988, 55:619-625.
21. Schlange T., Matsuda Y., Lienhard S., Huber A., Hynes N.E. Autocrine WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transactivation. Breast Cancer Res. 2007, 9:R63.
22. Nakashima T., Liu D., Nakano J., Ishikawa S., Yokomise H., Ueno M., Kadota K., Huang C.L. Wnt1 overexpression associated with tumor proliferation and a poor prognosis in non-small cell lung cancer patients. Oncol. Rep. 2008, 19:203-209.
23. He B., You L., Uematsu K., Xu Z., Lee A.Y., Matsangou M., McCormick F., Jablons D.M. A monoclonal antibody against Wnt-1 induces apoptosis in human cancer cells. Neoplasia 2004, 6:7-14.
24. He B., Reguart N., You L., Mazieres J., Xu Z., Lee A.Y., Mikami I., McCormick F., Jablons D.M. Blockade of Wnt-1 signaling induces apoptosis in human colorectal cancer cells containing downstream mutations. Oncogene 2005, 24:3054-3058.
25. Wei W., Chua M.S., Grepper S., So S.K. Blockade of Wnt-1 signaling leads to anti-tumor effects in hepatocellular carcinoma cells. Mol. Cancer 2009, 8:76.
26. Mizushima T., Nakagawa H., Kamberov Y.G., Wilder E.L., Klein P.S., Rustgi A.K. Wnt-1 but not epidermal growth factor induces beta-catenin/T-cell factor-dependent transcription in esophageal cancer cells. Cancer Res. 2002, 62:277-282.
27. Korinek V., Barker N., Morin P.J., van Wichen D., de Weger R., Kinzler K.W., Vogelstein B., Clevers H. Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma. Science 1997, 275:1784-1787.
28. Aubert J., Dunstan H., Chambers I., Smith A. Functional gene screening in embryonic stem cells implicates Wnt antagonism in neural differentiation. Nat. Biotechnol. 2002, 20:1240-1245.
29. Haegele L., Ingold B., Naumann H., Tabatabai G., Ledermann B., Brandner S. Wnt signalling inhibits neural differentiation of embryonic stem cells by controlling bone morphogenetic protein expression. Mol. Cell Neurosci. 2003, 24:696-708.
30. Barker N., van Es J.H., Kuipers J., Kujala P., van den Born M., Cozijnsen M., Haegebarth A., Korving J., Begthel H., Peters P.J., Clevers H. Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature 2007, 449:1003-1007.
31. Liebner S., Cattelino A., Gallini R., Rudini N., Iurlaro M., Piccolo S., Dejana E. Beta-catenin is required for endothelial-mesenchymal transformation during heart cushion development in the mouse. J. Cell Biol. 2004, 166:359-367.
32. Curtin J.C., Lorenzi M.V. Drug discovery approaches to target Wnt signaling in cancer stem cells. Oncotarget 2010, 1:563-577.
33. Thiery J.P., Acloque H., Huang R.Y., Nieto M.A. Epithelial-mesenchymal transitions in development and disease. Cell 2009, 139:871-890.
34. Mani S.A., Guo W., Liao M.J., Eaton E.N., Ayyanan A., Zhou A.Y., Brooks M., Reinhard F., Zhang C.C., Shipitsin M., Campbell L.L., Polyak K., Brisken C., Yang J., Weinberg R.A. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008, 133:704-715.